Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5671227 | 0.81 | MAPT (0.33) | MAPTCACNA1BAPBA1HTT | |
| SCHEMBL28430072 | 0.75 | HTT (0.35) | MAPTCACNA1BAPBA1HTT | |
| SCHEMBL7590961 | 0.73 | HTT (0.34) | MAPTCACNA1BAPBA1HTT | |
| SCHEMBL18498604 | 0.72 | MAPT (0.33) | MAPTCACNA1BAPBA1TSHR | |
| SCHEMBL3942986 | 0.71 | MAPT (0.33) | MAPTCACNA1BAPBA1HTT | |
| SCHEMBL28401523 | 0.71 | LMNA (0.43) | MAPTCACNA1BAPBA1CYP3A4TSHR | |
| SCHEMBL15105913 | 0.69 | TSHR (0.35) | HTTTSHRALDH1A1 | |
| SCHEMBL9305418 | 0.69 | HTT (0.42) | MAPTHTTTSHRALDH1A1 | |
| SCHEMBL623307 | 0.69 | — | — | |
| SCHEMBL10771737 | 0.69 | HTT (0.42) | MAPTHTTTSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002042288-A1 | PROCESS FOR PREPARING (-)-(18-CROWN-6)-2,3,11,12-TETRACARBOXYLIC ACID, AND (-)-CHIRAL STATIONARY PHASES FOR RESOLUTION OF RACEMIC COMPOUNDS USING THE SAME | RSTECH CO., LTD (KR) | 2002-05-30 | — | — | WO | disclosed |